Abbott Gets to Join Troubled Stent Market

Abbott just said the FDA approved its Xience stent.
Everyone knew it was in the works; the question now is what Xience means for a U.S. stent market that fell some 40% last year on safety worries and suggestions that the devices, used to prop open clogged arteries, have been overused. Abbott’s in good shape to [...]